The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Pseudoprogression of brain tumors
Open accessAbstract
This review describes the definition, incidence, clinical implications, and magnetic resonance imaging (MRI) findings of pseudoprogression of brain tumors, in particular, but not limited to, high‐grade glioma. Pseudoprogression is an important clinical problem after brain tumor treatment, interfering not only with day‐to‐day patient care but also the execution and interpretation of clinical trials. Radiologically, pseudoprogression is defined as a new or enlarging area(s) of contrast agent enhancement, in the absence of true tumor growth, which subsides or stabilizes without a change in therapy. The clinical definitions of pseudoprogression have been quite variable, which may explain some of the differences in reported incidences, which range from 9–30%. Conventional structural MRI is insufficient for distinguishing pseudoprogression from true progressive disease, and advanced imaging is needed to obtain higher levels of diagnostic certainty. Perfusion MRI is the most widely used imaging technique to diagnose pseudoprogression and has high reported diagnostic accuracy. Diagnostic performance of MR spectroscopy (MRS) appears to be somewhat higher, but MRS is less suitable for the routine and universal application in brain tumor follow‐up. The combination of MRS and diffusion‐weighted imaging and/or perfusion MRI seems to be particularly powerful, with diagnostic accuracy reaching up to or even greater than 90%. While diagnostic performance can be high with appropriate implementation and interpretation, even a combination of techniques, however, does not provide 100% accuracy. It should also be noted that most studies to date are small, heterogeneous, and retrospective in nature. Future improvements in diagnostic accuracy can be expected with harmonization of acquisition and postprocessing, quantitative MRI and computer‐aided diagnostic technology, and meticulous evaluation with clinical and pathological data. Level of Evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;48:571–589.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Self-citationImmunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Self-citationTofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Alsop, D. C., Detre, J. A., Golay, X., Günther, M., Hendrikse, J., Hernandez‐Garcia, L., Lu, H., MacIntosh, B. J., Parkes, L. M., Smits, M., et al. (2015) · Magnetic Resonance in Medicine · doi:10.1002/mrm.25197 · Cited by 2,206
Self-citationDiffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Padhani, A. R., Liu, G., Mu-Koh, D., Chenevert, T. L., Thoeny, H. C., Takahara, T., Dzik-Jurasz, A., Ross, B. D., Van Cauteren, M., Collins, D., et al. (2009) · Neoplasia · doi:10.1593/neo.81328 · Cited by 1,989
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Self-citationPseudoprogression and Immune-Related Response in Solid Tumors
Chiou, V. L., & Burotto, M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6870 · Cited by 903
Zacharaki, E. I., Wang, S., Chawla, S., Soo Yoo, D., Wolf, R., Melhem, E. R., & Davatzikos, C. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22147 · Cited by 855
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Okada, H., Weller, M., Huang, R., Finocchiaro, G., Gilbert, M. R., Wick, W., Ellingson, B. M., Hashimoto, N., Pollack, I. F., Brandes, A. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00088-1 · Cited by 781
Levin, V. A., Bidaut, L., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S., Loghin, M., Gilbert, M. R., & Jackson, E. F. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 729
Boxerman, J. L., Schmainda, K. M., & Weisskoff, R. M. (2006) · PubMed · Cited by 686
Kumar, A. J., Leeds, N. E., Fuller, G. N., Van Tassel, P., Maor, M. H., Sawaya, R. E., & Levin, V. A. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv36377 · Cited by 669
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
(2015) · Neuro-Oncology · doi:10.1093/neuonc/nov095 · Cited by 663
Zhou, J., Tryggestad, E., Wen, Z., Lal, B., Zhou, T., Grossman, R., Wang, S., Yan, K., Fu, D.-X., Ford, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2268 · Cited by 526
Ruben, J. D., Dally, M., Bailey, M., Smith, R., McLean, C. A., & Fedele, P. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.12.002 · Cited by 492
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Koshy, M., Villano, J. L., Dolecek, T. A., Howard, A., Mahmood, U., Chmura, S. J., Weichselbaum, R. R., & McCarthy, B. J. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0738-7 · Cited by 481
Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials
Ellingson, B. M., Wen, P. Y., & Cloughesy, T. F. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0507-6 · Cited by 476
Sugahara, T., Korogi, Y., Kochi, M., Ikushima, I., Hirai, T., Okuda, T., Shigematsu, Y., Liang, L., Ge, Y., Ushio, Y., et al. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.6.9843274 · Cited by 460
Hu, L. S., Baxter, L. C., Smith, K. A., Feuerstein, B. G., Karis, J. P., Eschbacher, J. M., Coons, S. W., Nakaji, P., Yeh, R. F., Debbins, J., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1377 · Cited by 396
Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades
Togao, O., Yoshiura, T., Keupp, J., Hiwatashi, A., Yamashita, K., Kikuchi, K., Suzuki, Y., Suzuki, S. O., Iwaki, T., Hata, N., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not158 · Cited by 392
Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy
Patterson, D. M., Padhani, A. R., & Collins, D. J. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1073 · Cited by 365
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
de Wit, M. C. Y., de Bruin, H. G., Eijkenboom, W., Sillevis Smitt, P. A. E., & van den Bent, M. J. (2004) · Neurology · doi:10.1212/01.wnl.0000133398.11870.9a · Cited by 357
Self-citationEarly necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Chamberlain, M. C., Glantz, M. J., Chalmers, L., Van Horn, A., & Sloan, A. E. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9241-y · Cited by 343
Paulson, E. S., & Schmainda, K. M. (2008) · Radiology · doi:10.1148/radiol.2492071659 · Cited by 327
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
Box, P. (2005) · Dkgest of the World Latest Medical Information · Cited by 299
A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice
Grade, M., Hernandez Tamames, J. A., Pizzini, F. B., Achten, E., Golay, X., & Smits, M. (2015) · Neuroradiology · doi:10.1007/s00234-015-1571-z · Cited by 298
Self-citationHamstra, D. A., Galbán, C. J., Meyer, C. R., Johnson, T. D., Sundgren, P. C., Tsien, C., Lawrence, T. S., Junck, L., Ross, D. J., Rehemtulla, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2363 · Cited by 281
Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity
Ellingson, B. M., Malkin, M. G., Rand, S. D., Connelly, J. M., Quinsey, C., LaViolette, P. S., Bedekar, D. P., & Schmainda, K. M. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22068 · Cited by 277
van Dijken, B. R. J., van Laar, P. J., Holtman, G. A., & van der Hoorn, A. (2017) · European Radiology · doi:10.1007/s00330-017-4789-9 · Cited by 259
Patel, P., Baradaran, H., Delgado, D., Askin, G., Christos, P., John Tsiouris, A., & Gupta, A. (2017) · Neuro-Oncology · doi:10.1093/neuonc/now148 · Cited by 250
Ellingson, B. M., Chung, C., Pope, W. B., Boxerman, J. L., & Kaufmann, T. J. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2375-2 · Cited by 246
Welker, K., Boxerman, J., Kalnin, A., Kaufmann, T., Shiroishi, M., Wintermark, M., & for the American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4341 · Cited by 243
Detection of Proton Chemical Exchange between Metabolites and Water in Biological Tissues
Guivel-Scharen, V., Sinnwell, T., Wolff, S. D., & Balaban, R. S. (1998) · Journal of Magnetic Resonance · doi:10.1006/jmre.1998.1440 · Cited by 241
Danchaivijitr, N., Waldman, A. D., Tozer, D. J., Benton, C. E., Brasil Caseiras, G., Tofts, P. S., Rees, J. H., & Jäger, H. R. (2008) · Radiology · doi:10.1148/radiol.2471062089 · Cited by 238
Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice
Thust, S. C., Heiland, S., Falini, A., Jäger, H. R., Waldman, A. D., Sundgren, P. C., Godi, C., Katsaros, V. K., Ramos, A., Bargallo, N., et al. (2018) · European Radiology · doi:10.1007/s00330-018-5314-5 · Cited by 236
Self-citationvan Zijl, P. C. M., Zhou, J., Mori, N., Payen, J., Wilson, D., & Mori, S. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10398 · Cited by 230
Zaiss, M., Windschuh, J., Paech, D., Meissner, J.-E., Burth, S., Schmitt, B., Kickingereder, P., Wiestler, B., Wick, W., Bendszus, M., et al. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.02.040 · Cited by 218
Hu, L. S., Eschbacher, J. M., Heiserman, J. E., Dueck, A. C., Shapiro, W. R., Liu, S., Karis, J. P., Smith, K. A., Coons, S. W., Nakaji, P., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos112 · Cited by 216
Cerebral radiation necrosis: A review of the pathobiology, diagnosis and management considerations
Rahmathulla, G., Marko, N. F., & Weil, R. J. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.09.011 · Cited by 211
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
Young, R. J., Gupta, A., Shah, A. D., Graber, J. J., Zhang, Z., Shi, W., Holodny, A. I., & Omuro, A. M. P. (2011) · Neurology · doi:10.1212/wnl.0b013e31821d74e7 · Cited by 195
Ryken, T. C., Aygun, N., Morris, J., Schweizer, M., Nair, R., Spracklen, C., Kalkanis, S. N., & Olson, J. J. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1330-0 · Cited by 195
Prager, A. J., Martinez, N., Beal, K., Omuro, A., Zhang, Z., & Young, R. J. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4218 · Cited by 193
Kong, D.-S., Kim, S. T., Kim, E.-H., Lim, D. H., Kim, W. S., Suh, Y.-L., Lee, J.-I., Park, K., Kim, J. H., & Nam, D.-H. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2286 · Cited by 192
Järnum, H., Steffensen, E. G., Knutsson, L., Fründ, E.-T., Simonsen, C. W., Lundbye-Christensen, S., Shankaranarayanan, A., Alsop, D. C., Jensen, F. T., & Larsson, E.-M. (2010) · Neuroradiology · doi:10.1007/s00234-009-0616-6 · Cited by 179
Ma, B., Blakeley, J. O., Hong, X., Zhang, H., Jiang, S., Blair, L., Zhang, Y., Heo, H., Zhang, M., van Zijl, P. C. M., et al. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25159 · Cited by 173
Predicting IDH mutation status in grade II gliomas using amide proton transfer‐weighted (APTw) MRI
Jiang, S., Zou, T., Eberhart, C. G., Villalobos, M. A. V., Heo, H., Zhang, Y., Wang, Y., Wang, X., Yu, H., Du, Y., et al. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26820 · Cited by 170
Chu, H. H., Choi, S. H., Ryoo, I., Kim, S. C., Yeom, J. A., Shin, H., Jung, S. C., Lee, A. L., Yoon, T. J., Kim, T. M., et al. (2013) · Radiology · doi:10.1148/radiol.13122024 · Cited by 162
Gahramanov, S., Muldoon, L. L., Varallyay, C. G., Li, X., Kraemer, D. F., Fu, R., Hamilton, B. E., Rooney, W. D., & Neuwelt, E. A. (2013) · Radiology · doi:10.1148/radiol.12111472 · Cited by 162
Mehrabian, H., Desmond, K. L., Soliman, H., Sahgal, A., & Stanisz, G. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2265 · Cited by 160
Zhang, H., Ma, L., Wang, Q., Zheng, X., Wu, C., & Xu, B. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.09.018 · Cited by 159
Wang, S., Martinez-Lage, M., Sakai, Y., Chawla, S., Kim, S. G., Alonso-Basanta, M., Lustig, R. A., Brem, S., Mohan, S., Wolf, R. L., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4474 · Cited by 158
Abbasi, A. W., Westerlaan, H. E., Holtman, G. A., Aden, K. M., van Laar, P. J., & van der Hoorn, A. (2017) · Clinical Neuroradiology · doi:10.1007/s00062-017-0584-x · Cited by 157
Magnetic Resonance Perfusion and Permeability Imaging in Brain Tumors
Lacerda, S., & Law, M. (2009) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2009.08.007 · Cited by 153
Hu, X., Wong, K., Young, G. S., Guo, L., & Wong, S. T. C. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22432 · Cited by 150
Hu, L., Baxter, L. C., Pinnaduwage, D. S., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1787 · Cited by 145
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Galldiks, N., Law, I. G., Pope, W. B., Arbizu, J., & Langen, K. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.020 · Cited by 141
Vascular morphology and angiogenesis in glial tumors
Plate, K. H., & Mennel, H. D. (1995) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80292-7 · Cited by 131
Predicting patterns of glioma recurrence using diffusion tensor imaging
Price, S. J., Jena, R., Burnet, N. G., et al. (2007) · European Radiology · doi:10.1007/s00330-006-0561-2 · Cited by 120
Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence
Radbruch, A., Fladt, J. C., Kickingereder, P., Wiestler, B., Nowosielski, M., Baumer, P., Schlemmer, H., Wick, A., Heiland, S., Wick, W., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou129 · Cited by 118
Distinguishing Recurrent High-grade Gliomas from Radiation Injury
Bisdas, S., Naegele, T., Ritz, R., Dimostheni, A., Pfannenberg, C., Reimold, M., Koh, T. S., & Ernemann, U. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.01.018 · Cited by 114
Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
Melguizo‐Gavilanes, I., Bruner, J. M., Guha‐Thakurta, N., Hess, K. R., & Puduvalli, V. K. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1774-5 · Cited by 109
Larroza, A., Moratal, D., Paredes‐Sánchez, A., Soria‐Olivas, E., Chust, M. L., Arribas, L., & Arana, E. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24913 · Cited by 105
Wick, W., Chinot, O. L., Bendszus, M., Mason, W. P., Henriksson, R., Saran, F. H., Nishikawa, R., Révil, C., Kerloëguen, Y., & Cloughesy, T. F. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now091 · Cited by 104
Lee, W. J., Choi, S. H., Park, C., Yi, K. S., Kim, T. M., Lee, S., Kim, J., Sohn, C., Park, S., & Kim, I. H. (2012) · Academic Radiology · doi:10.1016/j.acra.2012.06.011 · Cited by 102
Kazda, T., Bulik, M., Pospíšil, P., et al. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.02.016 · Cited by 97
Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy
van West, S. E., de Bruin, H. G., van de Langerijt, B., Swaak‐Kragten, A. T., van den Bent, M. J., & Taal, W. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now194 · Cited by 94
Gasparetto, E. L., Pawlak, M. A., Patel, S. H., Huse, J. T., Woo, J. H., Krejza, J., Rosenfeld, M. R., O’Rourke, D. M., Lustig, R. A., Melhem, E. R., et al. (2009) · Radiology · doi:10.1148/radiol.2502071444 · Cited by 92
Song, Y. S., Choi, S. H., Park, C., Yi, K. S., Lee, W. J., Yun, T. J., Kim, T. M., Lee, S., Kim, J., Sohn, C., et al. (2013) · Korean Journal of Radiology · doi:10.3348/kjr.2013.14.4.662 · Cited by 92
Anzalone, N., Castellano, A., Cadioli, M., Conte, G. M., Cuccarini, V., Bizzi, A., Grimaldi, M., Costa, A., Grillea, G., Vitali, P., et al. (2018) · Radiology · doi:10.1148/radiol.2017170362 · Cited by 90
Clinically feasible NODDI characterization of glioma using multiband EPI at 7 T
Wen, Q., Kelley, D. A. C., Banerjee, S., Lupo, J. M., Chang, S. M., Xu, D., Hess, C. P., & Nelson, S. J. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.08.017 · Cited by 88
State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications
Viallon, M., Cuvinciuc, V., Delattre, B. M. A., Merlini, L., Barnaure, I., Toso-Patel, S., Becker, M., Lövblad, K., & Haller, S. (2015) · Neuroradiology · doi:10.1007/s00234-015-1500-1 · Cited by 88
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma
Shiroishi, M. S., Boxerman, J. L., & Pope, W. B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov179 · Cited by 87
Nguyen, H. S., Milbach, N., Hurrell, S. L., Cochran, E. J., Connelly, J., Bovi, J. A., Schultz, C. J., Mueller, W. M., Rand, S. D., Schmainda, K. M., et al. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4898 · Cited by 76
Park, J. E., Kim, H. S., Goh, M. J., Kim, S. J., & Kim, J. H. (2015) · Radiology · doi:10.1148/radiol.14141414 · Cited by 62
Topkan, E., Topuk, S., Oymak, E., Parlak, C., & Pehlivan, B. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318210f54a · Cited by 59
Hirai, T., Kitajima, M., Nakamura, H., Okuda, T., Sasao, A., Shigematsu, Y., Utsunomiya, D., Oda, S., Uetani, H., Morioka, M., et al. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2725 · Cited by 59
Zach, L., Guez, D., Last, D., Daniels, D., Grober, Y., Nissim, O., Hoffmann, C., Nass, D., Talianski, A., Spiegelmann, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052008 · Cited by 56
Chaddad, A., & Tanougast, C. (2016) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-016-1461-5 · Cited by 55
Ye, J., Bhagat, S. K., Li, H., Luo, X., Wang, B., Liu, L., & Yang, G. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3225 · Cited by 53
Thomsen, H. S., Steffensen, E. G., & Larsson, E.-M. (2011) · Acta Radiologica · doi:10.1258/ar.2011.110242 · Cited by 52
MRI patterns of T 1 enhancing radiation necrosis versus tumour recurrence in high‐grade gliomas
Reddy, K., Westerly, D., & Chen, C. (2013) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2012.02472.x · Cited by 51
Liu, Z., Yan, L., Hu, Y., Sun, Y., Tian, Q., Nan, H., Yu, Y., Sun, Q., Wang, W., & Cui, G. (2017) · BMC Medical Imaging · doi:10.1186/s12880-017-0183-y · Cited by 51
What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent
Várallyay, C. G., Tóth, G. B., Fu, R. F., Netto, J. P., Firkins, J. L., Ambady, P., & Neuwelt, E. A. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5188 · Cited by 51
Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
McConnell, H., Schwartz, D. L., Richardson, B. E., Woltjer, R. L., Muldoon, L. L., & Neuwelt, E. A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.03.009 · Cited by 50
Reimer, C., Deike‐Hofmann, K., Graf, M., Reimer, P., Wiestler, B., Floca, R. O., Kickingereder, P., Schlemmer, H.-P., Wick, W., Bendszus, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174620 · Cited by 50
Booth, T. C., Larkin, T. J., Yuan, Y., Kettunen, M. I., Dawson, S., Scoffings, D. J., Canuto, H. C., Vowler, S. L., Kirschenlohr, H. L., Hobson, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176528 · Cited by 50
Bulik, M., Kazda, T., Šlampa, P., & Jančálek, R. (2015) · BioMed Research International · doi:10.1155/2015/641023 · Cited by 47
Impact of MRI head placement on glioma response assessment
Reuter, M., Gerstner, E. R., Rapalino, O., Batchelor, T. T., Rosen, B. R., & Fischl, B. R. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1403-8 · Cited by 47
Impact of imaging measurements on response assessment in glioblastoma clinical trials
Reardon, D. A., Ballman, K., Buckner, J. C., Chang, S. M., & Ellingson, B. M. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou286 · Cited by 41
Jafari‐Khouzani, K., Loebel, F., Bogner, W., Rapalino, O., González, R. G., Gerstner, E. R., Chi, A. S., Batchelor, T. T., Rosen, B. R., Unkelbach, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now100 · Cited by 41
Lopez, C., Nagornaya, N., Parra, N. A., Kwon, D., Ishkanian, F., Markoe, A. M., Maudsley, A. A., & Stoyanova, R. S. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.11.011 · Cited by 39
Karavaeva, E., Harris, R. J., Leu, K., Shabihkhani, M., Yong, W. H., Pope, W. B., Lai, A., Nghiemphu, P. L., Liau, L. M., Chen, W., et al. (2014) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0807-3 · Cited by 35
Zhang, H., Ma, L., Shu, C., Wang, Y., & Dong, L.-Q. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.02.038 · Cited by 33
Taal, W., Brandsma, D., de Bruin, H. G., Bromberg, J. E. C., Swaak‐Kragten, A. T., Eijkenboom, W. M. H., & van den Bent, M. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.2009 · Cited by 29
Microvascular adaptive changes in experimental endogenous brain gliomas.
Bulnes, S., Bilbao, J., & Lafuente, J. V. (2009) · PubMed · doi:10.14670/hh-24.693 · Cited by 28
Wang, S., Chen, Y., Lal, B., Ford, E., Tryggestad, E. J., Armour, M., Yan, K., Laterra, J., & Zhou, J. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0719-x · Cited by 28
Fujimoto, D. K., von Eyben, R., Gibbs, I. C., Chang, S. D., Li, G., Harsh, G. R., Hancock, S., Fischbein, N. J., & Soltys, S. G. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2647-x · Cited by 27
Imaging of nuclear Overhauser enhancement at 7 and 3 T
Shen, Y., Xiao, G., Shen, Z., Zhang, X., Tang, X., Hu, W., Zhang, Z., Guan, J., & Wu, R. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3735 · Cited by 26
Petersen, J., Bendszus, M., Debus, J., Heiland, S., & Maier-Hein, K. H. (2017) · Journal of medical imaging · doi:10.1117/1.jmi.4.3.034001 · Cited by 3
Cited by
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Metadata
- Authors
- Thust, S. C., van den Bent, M. J., & Smits, M.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2018-05-07
- Volume
- 48
- Issue
- 3
- Pages
- 571-589
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2883592798
- Cited by
- 304
- References
- 100
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.